Protocol Ledger

NCT03121209 · Phase III · COMPLETED

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)

Interventional Phase III clinical trial protocol NCT03121209 sponsored by Columbia University in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-01-18 Enrollment: 392 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03121209
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)392 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03121209
Protocol FieldVerified Registry Value
NCT IdentifierNCT03121209
Consolidated Lead SponsorColumbia University
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment392 participants (ACTUAL)
Registered Start Date2018-01-18
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI